This report presents surveillance data on Clostridioides (Clostridium) difficile infection (CDI) in acute care hospitals in European Union/European Economic Area (EU/EEA) countries, the UK, and Serbia.
For 2020, 29 EU/EEA countries reported 123 062 confirmed cases of campylobacteriosis. This represents a reduction of 26.0% compared with 2019 (UK cases excluded).
Campylobacteriosis is the most frequently reported food- and waterborne disease in the EU/EEA. In 2018, 30 EU/EEA countries reported 250 384 confirmed cases of campylobacteriosis.
This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
From 23–26 April 2024, experts from the European Centre for Disease Prevention and Control (ECDC) and the African Centres for Disease Control and Prevention (Africa CDC) met in Stockholm, Sweden, to exchange expertise on surveillance, data management and epidemic intelligence.
This report provides an integrated analysis of relationships between antimicrobial consumption in humans and food- producing animals and the occurrence of antimicrobial resistance in bacteria from humans and food- producing animals, respectively.
This annual meeting of National ECDC Correspondents focused on the technical cooperation developments over the last year in the areas of disease surveillance, microbiology, preparedness and response.
The seventh ‘Exchange of Experts’ programme meeting for European Neighbourhood Policy partner countries took place on 14-15 November 2023 at Statens Serum Institut in Copenhagen, Denmark.
For 2022, 29 countries (27 European Union (EU) Member States and two European Economic Area (EEA) countries – Iceland and Norway) reported data on antimicrobial consumption.